Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Aion Therapeutic Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Post by RisePrize007on Jan 11, 2024 10:35am
74 Views
Post# 35821343

The psychedelics industry is young but promising

The psychedelics industry is young but promising

The psychedelic industry is maturing after the investment boom of 2020/2021, and patient long-term investors looking for opportunities to diversify their portfolios have some options when it comes to psychedelic stocks. 

As clinical trials and research continue to demonstrate the potential benefits of psychedelic-assisted therapy (PAT), companies in this space are attracting more attention.  https://investingnews.com/daily/life-science-investing/psychedelics-investing/psychedelics-market-update/

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities